News and Conferences

Congratulations to Dr. Jack Prenderville, Head of Research at Transpharmation's Irish site, on his nomination to the position of Adjunct Assistant Professor in the Department of Physiology at Trinity College Dublin. For a number of years Jack has made a valuable contribution to teaching and research, delivering neuropharmacology lectures and supervising undergraduate research students within the Department. This recognition is well deserved and adds an additional dimension to his role within Transpharmation.

AAIC has become a regular meeting on our calendar and this year we are showcasing our latest assay - ‘Establishment of a reversal learning assay in rats to investigate the effects of novel compounds on executive function’. This expands on our well-established cognition platform and brings a new translational aspect to our portfolio.

We are pleased to announce an enterprise partnership with Professor Andrew Harkin, Trinity College Institute of neuroscience (TCIN) co-funded by Irish research Council (IRC) and Transpharmation Ltd. This partnership, initially supported for a four-year period, will establish a clinically relevant experimental platform to facilitate the development of new therapeutics for the treatment of Parkinson’s disease.

11th May to 12th May 2020, London, United Kingdom.

Transpharmation were pleased to join this virtual event. For details of our work in this area please go to publications.

For more information please visit: Pain Therapeutics Conference

During these unprecedented times, good communication and maintaining contact is more important than ever. That's why at Transpharmation we're making use of all the resources available for holding regular meetings with our clients to discuss ongoing and future projects. Although some of us are working from home and juggling family commitments, we remain close to you. We're all in this together and it's nice to stay in touch.

Pharma Tech Outlook magazine have named Transpharmation ‘company of the year’ in their ‘top 5 UK CRO’s’ feature. We’re proud of this achievement on behalf of all the clients that we’ve worked with over the years and it’s a great start to our 10th anniversary year.

We are delighted to announce that Transpharmation Ltd is to be one of the partners enlisted in the EU-funded first international project to study dystrophin in the brain in Duchenne and Becker Muscular Dystrophy (DMD and BMD).

A focus on sleep, depression and chemobrain in collaboration with the University of Hertfordshire.For patients suffering with chronic neuropathic pain, (e.g. diabetes, chemotherapy) the need for suitable novel therapies is imperative. The key to developing new treatments lies in identifying measurable endpoints in both preclinical and human subjects to aid translation of preclinical results to the clinic.Building on the impressive work that Transpharmation’s Dr Amy Fisher has already accomplished, we have partnered with Dr Lisa Lione's team at the University of Hertfordshire to successfully recruit multi award winning PhD student Michael Lanigan to focus exclusively on refining novel endpoints for our neuropathic pain assays. Michael was recently awarded the prestigious 2019 British Pharmacological Society Undergraduate Prize.Using our strengths in EEG, MMN, cognition and biomarker analysis we will be working with UoH to better understand the behavioural and biochemical impact of pain and analgesia. We hope this work will create better translational preclinical research models, refine the drug discovery process for our clients and lead to the development of new medicines for patients suffering with neuropathic pain.

On Monday 9th December, Transpharmation’s scientific expert Dr Sandor Kantor will be presenting his work on ''Altered EEG oscillations as correlates of abnormal brain function in neuropsychiatric diseases'' as part of the Trinity College Institute of Neuroscience Seminar Series 2019. For further information please contact our Dublin based science lead Jack Prenderville.